Sign Out
Tigecycline (Tigilyn) is not approved for clinical indications other than complicated skin and soft tissue infections, and complicated intra-abdominal infections. The use of Tigecycline (Tigilyn) in non-approved indications is not recommended.
Anaphylaxis/anaphylactoid reactions, potentially life-threatening, have been reported with Tigecycline (Tigilyn).
Use in Pregnancy: Tigecycline (Tigilyn) may cause fetal harm when administered to a pregnant woman.
The use of Tigecycline (Tigilyn) during tooth development (last half of pregnancy, infancy, and childhood to the age of 8 years) may cause permanent discoloration of the teeth.
